• In June 2025, Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) announced that the FDA granted Fast Track designation to AMX0114, ...

Measuring the electrical activity of muscles in the neck in ALS may be easier for some patients than using the tongue for ...

Certain subsets of microglia were found to be enriched in nervous system tissues from people with amyotrophic lateral ...

A patient with amyotrophic lateral sclerosis (ALS) has become the first person in the world to control an iPad entirely by ...

Salym Liufau was at a family birthday party in 2022 when she squatted to pick up her kids, a motion she’d done a million ...

Amyotrophic lateral sclerosis (ALS), known as Lou Gehrig's disease, is an incurable neurological disorder affecting motor ...

The amyotrophic lateral sclerosis (ALS) treatment market was valued at USD 791.90 Million in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 5.40% from 2025 to 2034.

Amyotrophic Lateral Sclerosis, ALS, is a horrible disease. Last week in a reversal of a decision the FDA made just a few months ago, their external advisory board approved a “novel” drug for ALS. What ...

Safety & Health First Responder Class on Amyotrophic Lateral Sclerosis (ALS) This event is designed to help all first responders be better prepared when responding to a call involving someone with ALS ...

Amyotrophic Lateral Sclerosis Treatment Market Distribution Channel Insights Hospital pharmacies held a significant revenue share in the amyotrophic lateral sclerosis (ALS) treatment market in ...